MCHPP vs ARM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 04, 2026

MCHPP

25.1
AI Score
VS
ARM Wins

ARM

29.9
AI Score

Investment Advisor Scores

MCHPP

25score
Recommendation
AVOID NEW MONEY

ARM

30score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric MCHPP ARM Winner
Forward P/E 0 151.5152 Tie
PEG Ratio 0 2.731 Tie
Revenue Growth 38.0% 22.4% MCHPP
Earnings Growth -81.6% 108.3% ARM
Tradestie Score 25.1/100 29.9/100 ARM
Profit Margin 9.3% 20.2% ARM
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

MCHPP 1M: +10.0% · 3M: -2.8% ARM 1M: +24.9% · 3M: +0.8%

Current Technical Phase

MCHPP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 63.2 · Price: $69.26

ARM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 56.6 · Price: $302.90

Fundamentals Snapshot

Metric MCHPP ARM
Market Cap — —
Forward P/E 0.0 141.6
Trailing P/E — 313.8
Revenue (TTM) — —
Revenue Growth 0.4% 0.2%
Gross Margin 0.6% 1.0%
Operating Margin 0.2% 0.1%
EPS 0.00 0.98
Dividend Yield 0.03% —

Frequently Asked Questions

Based on our detailed analysis, ARM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.